Head-to-head · Value Score
bmiMD vs TeleHealth Med
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, TeleHealth Med a 69. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameTeleHealth Med
#266 · Grade C · Watch List
Est. first month
From $147/mo (starting dose, compounded)
Save ~89% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 69 — an est. $99/mo first month, with no teaser step-up baked in. TeleHealth Med isn't out of it: Shoppers who want georgia Inc.-incorporated GLP-1 with honest testimonial disclosure.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | TeleHealth Med |
|---|---|---|
| Value Score | 89 (A) | 69 (C) |
| Est. first month | $99/mo | From $147/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~89% |
| Semaglutide | $99/mo | From $147/mo (starting dose, compounded) |
| Tirzepatide | $139/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
TeleHealth Med
TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…
Why it's a deal
- Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
- Publishes the FDA compounded-medication disclaimer
- 503A pharmacy designation stated in the FAQ
- Honest disclosure that testimonials are compensated and results aren't independently verified
- Both injectable and sublingual forms offered
The fine print
- Specific 503A pharmacy partner not named
- LegitScript ID number not shown in text — only a verification link
- Full states-served list not disclosed
- Named medical director not disclosed
- Dose tiers beyond the $147/mo starting price not published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to TeleHealth Med.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.